Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa

AbbVie

Status: Completed

Conditions: Hidradenitis Suppurativa (HS)

Study type: Observational

Funder types: Industry

Identifiers

NCT03894956

P18-835

Details and patient eligibility

About

The objective of this study is to evaluate the long-term safety and effectiveness of Humira in patients with Hidradenitis Suppurativa (HS) in real-world clinical practice in Japan.

Enrollment: 46 patients

Sex: All

Ages: Under 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants who have been prescribed Humira by their treating physician as per routine clinical practice for the treatment of HS.

Exclusion criteria

• Participants previously treated with Humira.
• Participants who do not provide consent.

Trial design

46 participants in 1 patient group

Participants with Hidradenitis Suppurativa (HS)

Description:

Participants who along with their treating physician have elected for treatment with Humira as per routine clinical practice for the treatment of HS